Bright Minds Biosciences (DRUG) Total Current Liabilities (2021 - 2026)
For the quarter ending Q1 2026, Total Current Liabilities changed N/A year-over-year to $2.8 million, compared with a TTM value of $2.8 million through Mar 2026, changed N/A, and an annual FY2025 reading of $1.7 million, up 337.87% over the prior year.
Bright Minds Biosciences (DRUG) has disclosed Total Current Liabilities for 6 consecutive years, with $2.8 million as the latest value for Q1 2026.
- Total Current Liabilities reached $2.8 million in Q1 2026 per DRUG's latest filing, up from $1.7 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $2.8 million in Q1 2026 and bottomed at $209499.0 in Q3 2023.
- Average Total Current Liabilities over 5 years is $1.2 million, with a median of $1.1 million recorded in 2022.
- Year-over-year, Total Current Liabilities tumbled 81.44% in 2023 and then skyrocketed 337.87% in 2025.
- Bright Minds Biosciences' Total Current Liabilities stood at $1.1 million in 2022, then plummeted by 81.44% to $209499.0 in 2023, then soared by 84.99% to $387552.9 in 2024, then soared by 337.87% to $1.7 million in 2025, then surged by 64.7% to $2.8 million in 2026.
- Per Business Quant, the three most recent readings for DRUG's Total Current Liabilities are $2.8 million (Q1 2026), $1.7 million (Q3 2025), and $387552.9 (Q3 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 16.35 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 1.70 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 636.40 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 66.94 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 13.42 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 3.88 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 5.11 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 1.35 Bn |
| 10 | Bright Minds Biosciences | 464.72 Mn | 405.19 Mn | - | 2.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.79 Mn |
| Dec 31, 2025 | 1.13 Mn |
| Sep 30, 2025 | 1.70 Mn |
| Jun 30, 2025 | 436,629.57 |
| Mar 31, 2025 | 444,609.02 |
| Dec 31, 2024 | 330,380.13 |
| Sep 30, 2024 | 387,552.88 |
| Sep 30, 2023 | 209,499.05 |
| Jun 30, 2023 | 536,598.36 |
| Mar 31, 2023 | 743,977.73 |
| Dec 31, 2022 | 389,049.88 |
| Sep 30, 2022 | 1.13 Mn |
| Sep 30, 2021 | 507,288.34 |